• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型隐球菌分离株对氟康唑和伊曲康唑的体外敏感性

In-vitro susceptibility of Cryptococcus neoformans isolates to fluconazole and itraconazole.

作者信息

Davey K G, Johnson E M, Holmes A D, Szekely A, Warnock D W

机构信息

PHLS Mycology Reference Laboratory, Public Health Laboratory, Kingsdown, Bristol, UK.

出版信息

J Antimicrob Chemother. 1998 Aug;42(2):217-20. doi: 10.1093/jac/42.2.217.

DOI:10.1093/jac/42.2.217
PMID:9738839
Abstract

The in-vitro susceptibilities of 143 isolates of Cryptococcus neoformans, collected from British patients between 1994 and 1996, to fluconazole and itraconazole were compared with those of 36 isolates collected between 1971 and 1985, 41 isolates collected between 1986 and 1989, and 43 Ugandan isolates collected in 1996. Testing was done with a broth microdilution method in YNB medium supplemented with glucose, incubation at 30 degrees C for 72 h, and an endpoint of 50% inhibition. The results showed that the MIC ranges, MIC50s and MIC90s of fluconazole and itraconazole for C. neoformans isolates from the UK have remained unchanged despite the recent widespread use of triazoles for long-term maintenance of patients with AIDS-associated cryptococcal meningitis. The MIC ranges, MIC50s and MIC90s of the 43 isolates from untreated Ugandan patients with AIDS were similar to those of the British isolates. Examination of our records for 1994-96 revealed six cases in which a four-fold or greater rise in the MIC of fluconazole was associated with relapsed cryptococcal meningitis.

摘要

对1994年至1996年间从英国患者中分离出的143株新型隐球菌的体外药敏情况进行了研究,比较了其对氟康唑和伊曲康唑的药敏情况,同时也对1971年至1985年间收集的36株、1986年至1989年间收集的41株以及1996年收集的43株乌干达分离株进行了同样的比较。采用肉汤微量稀释法在添加葡萄糖的YNB培养基中进行检测,在30℃下孵育72小时,以50%抑制率作为终点。结果显示,尽管最近三唑类药物被广泛用于艾滋病相关隐球菌性脑膜炎患者的长期维持治疗,但英国新型隐球菌分离株对氟康唑和伊曲康唑的MIC范围、MIC50和MIC90并未改变。43株来自未经治疗的乌干达艾滋病患者的分离株的MIC范围、MIC50和MIC90与英国分离株相似。查阅我们1994 - 96年的记录发现,有6例氟康唑MIC升高四倍或更多与隐球菌性脑膜炎复发有关。

相似文献

1
In-vitro susceptibility of Cryptococcus neoformans isolates to fluconazole and itraconazole.新型隐球菌分离株对氟康唑和伊曲康唑的体外敏感性
J Antimicrob Chemother. 1998 Aug;42(2):217-20. doi: 10.1093/jac/42.2.217.
2
Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain: 1994-1996 and 1997-2005.西班牙1994 - 1996年及1997 - 2005年HIV感染患者中新型隐球菌分离株对氟康唑、伊曲康唑和伏立康唑的抗真菌药敏情况
Chemotherapy. 2007;53(4):300-5. doi: 10.1159/000102585. Epub 2007 May 10.
3
Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients.新型隐球菌的氟康唑药敏试验:两种肉汤微量稀释法的比较及乌干达艾滋病患者分离株的临床相关性
J Clin Microbiol. 1998 Oct;36(10):2874-6. doi: 10.1128/JCM.36.10.2874-2876.1998.
4
In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.在体外对从塞尔维亚患者脑脊液和血液中分离的新型隐球菌的两性霉素 B、5-氟胞嘧啶、氟康唑和伊曲康唑的抗真菌活性。
J Mycol Med. 2012 Sep;22(3):243-8. doi: 10.1016/j.mycmed.2012.06.002. Epub 2012 Aug 10.
5
Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiânia city, Goiás, Brazil.巴西戈亚斯州戈亚尼亚市新型隐球菌临床和环境分离株的抗真菌药敏性
Rev Inst Med Trop Sao Paulo. 2005 Sep-Oct;47(5):253-6. doi: 10.1590/s0036-46652005000500003. Epub 2005 Nov 16.
6
Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.乌干达艾滋病患者中新隐球菌分离株的分子流行病学及抗真菌药敏性
Diagn Microbiol Infect Dis. 1998 Nov;32(3):191-9. doi: 10.1016/s0732-8893(98)00095-9.
7
In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa.伏立康唑、氟康唑和伊曲康唑对来自美国和非洲的566株新生隐球菌临床分离株的体外活性。
Antimicrob Agents Chemother. 1999 Jan;43(1):169-71. doi: 10.1128/AAC.43.1.169.
8
Decreasing fluconazole susceptibility of clinical South African Cryptococcus neoformans isolates over a decade.南非新型隐球菌临床分离株氟康唑敏感性在十年间逐渐降低。
PLoS Negl Trop Dis. 2020 Mar 31;14(3):e0008137. doi: 10.1371/journal.pntd.0008137. eCollection 2020 Mar.
9
Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.念珠菌属和新型隐球菌抗真菌药敏试验的Etest法多中心评估。英国抗菌化疗学会工作组
J Antimicrob Chemother. 1998 Sep;42(3):321-31. doi: 10.1093/jac/42.3.321.
10
In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.泊沙康唑(Sch 56592)与伊曲康唑和氟康唑相比,对3685株念珠菌属和新型隐球菌临床分离株的体外活性。
Antimicrob Agents Chemother. 2001 Oct;45(10):2862-4. doi: 10.1128/AAC.45.10.2862-2864.2001.

引用本文的文献

1
Antifungal Resistance in Cryptococcal Infections.隐球菌感染中的抗真菌耐药性
Pathogens. 2024 Jan 29;13(2):128. doi: 10.3390/pathogens13020128.
2
Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study.科罗克氏球遗传多样性和混合感染在科特迪瓦 HIV 患者中的研究:一项随访研究。
PLoS Negl Trop Dis. 2019 Nov 18;13(11):e0007812. doi: 10.1371/journal.pntd.0007812. eCollection 2019 Nov.
3
Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
印度中部中央邦贾巴尔普尔市临床和环境来源的新型隐球菌及格特隐球菌分离株的抗真菌药敏性
Braz J Microbiol. 2015 Oct-Dec;46(4):1125-33. doi: 10.1590/S1517-838246420140564. Epub 2015 Oct 27.
4
Efflux-mediated antifungal drug resistance.外排介导的抗真菌药物耐药性。
Clin Microbiol Rev. 2009 Apr;22(2):291-321, Table of Contents. doi: 10.1128/CMR.00051-08.
5
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.1997年至2007年ARTEMIS DISK全球抗真菌监测研究结果:采用CLSI标准化纸片扩散法对非念珠菌酵母菌种对氟康唑和伏立康唑敏感性进行的10.5年分析。
J Clin Microbiol. 2009 Jan;47(1):117-23. doi: 10.1128/JCM.01747-08. Epub 2008 Nov 12.
6
Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004).新型隐球菌抗真菌药敏的全球趋势(1990年至2004年)
J Clin Microbiol. 2005 May;43(5):2163-7. doi: 10.1128/JCM.43.5.2163-2167.2005.
7
In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia.两性霉素B、氟康唑和伏立康唑对来自非洲和柬埔寨的162株新型隐球菌分离株的体外活性。
Eur J Clin Microbiol Infect Dis. 2004 Jun;23(6):506-8. doi: 10.1007/s10096-004-1136-2. Epub 2004 May 13.
8
Antifungal susceptibilities of Cryptococcus neoformans.新型隐球菌的抗真菌药敏性
Emerg Infect Dis. 2004 Jan;10(1):143-5. doi: 10.3201/eid1001.020779.
9
Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998.美国新型隐球菌分离株对抗真菌药物的敏感性趋势:1992年至1994年及1996年至1998年。
Antimicrob Agents Chemother. 2001 Nov;45(11):3065-9. doi: 10.1128/AAC.45.11.3065-3069.2001.
10
Cryptococcal Meningitis.隐球菌性脑膜炎
Curr Treat Options Neurol. 2001 Sep;3(5):413-426. doi: 10.1007/s11940-001-0029-2.